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Abstract
Background: Studies have shown that residents in nursing homes often are exposed to inappropriate medication.
Particular concern has been raised about the consumption of psychoactive drugs, which are commonly prescribed
for nursing home residents suffering from dementia. This review is an update of a Norwegian systematic review
commissioned by the Norwegian Directorate of Health. The purpose of the review was to identify and summarise
the effect of interventions aimed at reducing potentially inappropriate use or prescribing of drugs in nursing
homes.
Methods: We searched for systematic reviews and randomised controlled trials in the Cochrane Library, MEDLINE,
EMBASE, ISI Web of Knowledge, DARE and HTA, with the last update in April 2010. Two of the authors
independently screened titles and abstracts for inclusion or exclusion. Data on interventions, participants,
comparison intervention, and outcomes were extracted from the included studies. Risk of bias and quality of
evidence were assessed using the Cochrane Risk of Bias Table and GRADE, respectively. Outcomes assessed were
use of or prescribing of drugs (primary) and the health-related outcomes falls, physical limitation, hospitalisation
and mortality (secondary).
Results: Due to heterogeneity in interventions and outcomes, we employed a narrative approach. Twenty
randomised controlled trials were included from 1631 evaluated references. Ten studies tested different kinds of
educational interventions while seven studies tested medication reviews by pharmacists. Only one study was found
for each of the interventions geriatric care teams, early psychiatric intervening or activities for the residents
combined with education of health care personnel. Several reviews were identified, but these either concerned
elderly in general or did not satisfy all the requirements for systematic reviews.
Conclusions: Interventions using educational outreach, on-site education given alone or as part of an intervention
package and pharmacist medication review may under certain circumstances reduce inappropriate drug use, but
the evidence is of low quality. Due to poor quality of the evidence, no conclusions may be drawn about the effect
of the other three interventions on drug use, or of either intervention on health-related outcomes.
Background
Several studies have shown that the prescription rate
and consumption of drugs in nursing homes are high
and that prescribing often is inappropriate [1-6]. Inap-
propriate use or prescribing of drugs comprises over-use
as well as underuse of drugs, prescribing of multiple
drugs with known interactions, for the wrong indication
or in wrong doses or for too long duration. Appropri-
ateness of prescribing can be assessed by validated tools
for reviewing drug utilisation [7]. As much as 40% of
prescriptions for residents in nursing homes may be
inappropriate [6]. Of particular concern is the high con-
sumption of psychotropic drugs, sedatives and sleep
medication. Residents in nursing homes often have a
complex and complicated illness profile ranging from
simultaneous occurrence of several chronic diseases,
depression, pain and sleep problems. The majority of
residents in nursing homes also suffer from dementia,
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with the psychiatric and behavioural symptoms this
often entails [3]. For these reasons, many residents use
several drugs simultaneously, with increased risk of
interactions between drugs, adverse effects and medica-
tion errors, with the possibility of increased morbidity
and mortality. It is, therefore, desirable to reduce poten-
tially inappropriate drug use. This review is an update of
a Norwegian systematic review in Norwegian commis-
sioned by the Norwegian Directorate of Health [8]. The
objective for this systematic review was to identify,
assess and summarise available scientific evidence about
the effect of interventions that could be used to reduce
potentially inappropriate use of drugs in nursing homes.
Methods
Search strategy
A search strategy was developed on the basis of the
inclusion criteria and included the following databases:
The Cochrane Library, MEDLINE, EMBASE, ISI Web of
Knowledge and the Database of Abstracts of Reviews of
Effects (DARE) and Health Technology Assessment
Database (HTA) at the Centre for Reviews and Dissemi-
nation (CRD). MEDLINE and EMBASE was searched
from their inception to August/September 2009 for sys-
tematic reviews and for randomized controlled trials for
the last five years to compensate for the time lag in the
Cochrane Central Register of Controlled Trials. No lan-
guage restrictions were added to the search algorithms.
We only searched for published literature. All searches
were updated in April 2010. The complete search strat-
egy is presented in Additional file 1, Table S1.
Inclusion criteria
Inclusion criteria were all studies of interventions aimed
wholly or partly at reducing potentially inappropriate use
or prescribing of drugs for elderly people in nursing
home settings and that measured drug use. Studies were
only included if the primary outcome, drug use, was
assessed by explicit or implicit criteria [7] or where speci-
fic drugs were targeted for reduction as defined by
authors. Secondary outcome measures were falls, hospital
admission, physical restraints and mortality. Comparison
interventions were care as usual or other interventions.
Study design inclusion criteria were high quality systema-
tic reviews of randomised controlled trials and/or pri-
mary studies with a randomised controlled design. For a
review to be considered systematic, three criteria had to
be fulfilled: a documented systematic search strategy, cri-
tical appraisal of included studies by at least two indepen-
dent reviewers and taking the quality of evidence into
consideration when drawing conclusions. Inclusion
criteria for language were Norwegian, Swedish, Danish,
Finish, English or German.
Exclusion criteria
Studies of the effect of withdrawal of drugs and studies
that otherwise did not satisfy all the inclusion criteria
were excluded.
Selection of studies
Two reviewers (LF, EG; LF, MCE) screened references
and abstracts independently for identification of studies
that potentially satisfied the inclusion criteria. If one
reviewer assessed a reference to be potentially relevant,
the full-text article was ordered. Each full-text report
was assessed independently by two reviewers (LF, MCE)
for inclusion or exclusion.
Assessment of risk of bias
Two reviewers (LF, MCE) assessed risk of bias for
results of included randomized controlled studies using
the Cochrane Collaboration’s “Risk of Bias Table” [9]. In
cases of disagreement, a third reviewer (GEV) was
involved until consensus was reached. Each outcome
within a study was assessed as of low, unclear or high
risk of bias, using summary evaluation according to the
table. When there was unclear risk of bias for key
domains, the summary risk of bias for the outcome was
also assessed as unclear. For cluster trials we added
three more domains to be assessed: baseline balance,
blinding of recruiters, and completeness of data for clus-
ters and health personnel. In addition, under biases
defined as ‘other’ in the table, we assessed the unit of
analysis. If matching had been used, we assessed
whether this had been adjusted for in the analysis.
When clusters are allocated simultaneously, conceal-
ment is not regarded as an issue. Accordingly, if it was
unclear whether clusters had been allocated all at once,
we rated concealment of allocation as ‘unclear’.
Data extraction, data synthesis and grading of evidence
When possible, we collected or calculated the relative
risk (RR) for dichotomous outcomes and mean differ-
ence between the groups with confidence intervals for
continuous outcomes. No meta-analysis was conducted,
partly because the execution, intensity and duration of
these types of interventions are very different and partly
because the outcome was measured in several different
ways and with different follow-up periods. We therefore
made a qualitative analysis and presented the data in
tables. The following data were extracted: participants,
intervention description and the degree of implementa-
tion, comparative interventions and outcomes.
The quality of the complete documentation of each of
the primary outcomes was assessed by GRADE (Grading
of Recommendations, Assessment, Development and
Evaluation: http://www.gradeworkinggroup.org).
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Results
We identified and assessed 1631 references (205 of these
from the update search) by title and abstract according
to inclusion and exclusion criteria. Of these, 57 refer-
ences (15 from the update) were further evaluated for
inclusion in full-text. Twenty-one publications (2 from
the update) of 20 randomised controlled trials met the
inclusion criteria [10-30], 15 of which were randomized
by clusters. A flow diagram of the selection process is
presented in Figure 1. None of the 19 identified review
articles were included in this paper, as they either failed
to meet the inclusion criteria of high quality systematic
reviews or because they reviewed studies of elderly in
general. Detailed reasons for exclusions of reviews and
randomised controlled trials are reported in ‘Excluded
Studies’ in Additional file 1, Table S2.
Risk of bias in included studies
The results in one study were assessed to have a low
risk of systematic bias, in five studies to have a high risk
and in the remaining 14 studies to have an unclear risk
of systematic bias (Additional file 1, Table S3). The
most common reasons for risk of bias were unclear
information on the generation of the randomization
sequence and/or concealment of allocation and incom-
plete follow-up of residents. In none of the cluster ran-
domized studies did the authors explicitly report
whether the persons recruiting residents for the trial
were blinded to group allocation. Two of these studies
were also assessed as having unit of analysis errors in
their analyses (McCallion 1999 [21], Schmidt 1998/
Claesson 1998 [26]).
Outcomes
In three studies the quality of drug prescribing was
assessed by using the Medication Appropriateness Index
(MAI) (Crotty 2004b [14], Crotty 2004c [15]) or a simi-
lar scoring tool developed for use in the study (Avorn
1992 [10]). MAI is a validated measure that assesses ten
criteria for each medication: Indication, effectiveness,
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Screening of 1 426 references 
identified through database 
searching and reference screening 
42 fulltext articles  
assessed for eligibility 
1 384 references not relevant 
Literature search update: 205 
references identified 
190 references not relevant 
15 articles assessed for eligibility 
24 articles excluded for not 
satisfying all inclusion criteria 
13 articles excluded for not 
satisfying all inclusion criteria 
20 randomized controlled trials 
included in qualitative synthesis 
18 randomized controlled trials 
included 
2 randomized controlled trials  
included 
Figure 1 Flow chart of study selection.
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dosage, correct directions, practical directions, drug-
drug interactions, drug-disease interactions, duplication,
duration and cost [7]. A weighted score is generated to
express the degree of prescribing appropriateness. Four
other studies evaluated the appropriateness of drugs
according to explicit criteria, using guidelines from the
Swedish Medical Product Agency (Schmidt 1998 [26]/
Claesson 1998 [12]), guidelines issued in connection
with OBRA (US Ombudsman Reconciliation Act) (Fur-
niss 2000 [17]), Beers’ criteria (Midlöv 2002 [23]) or a
novel algorithm developed for the study purpose (Patter-
son 2010 [29]). Beers’ criteria are a list of drugs that
should be avoided in the elderly in general or in elderly
with specific disorders and gives indications of maxi-
mum doses [31]. Reduction in the overall number of
drugs prescribed were measured in two studies (Caval-
lieri 1993 [11], Zermansky 2006 [28]) while the remain-
ing 11 studies measured reduction in prescription of
targeted classes of drugs. The follow-up period in all
studies ranged from 1 month to 12 months (details are
given in GRADE tables).
Categorisation of interventions
We classified the interventions into seven categories on
the basis of their main component:
• Educational outreach initiatives (2 studies)
• Educational meetings (5 studies)
• Educational meetings with at least one additional
intervention (3 studies)
• Medication review (7 studies)
• Geriatric assessment and care teams (1 study)
• Early psychiatric intervention (1 study)
• Activity program interventions for residents (1
study)
All interventions were compared to usual practice.
Educational outreach interventions
Two studies conducted in 32 nursing homes with a total
of 1538 residents examined the effect of educational
outreach interventions (Avorn 1992 [10]; Crotty 2004a
[13]). A description of the participants, interventions
and outcomes is presented in Table 1. An external clini-
cal pharmacist visited the physicians that cared for the
residents in the intervention nursing homes to provide
information on appropriate drug use. The pharmacist in
Crotty 2004a [13] provided audit information on falls
and psychotropic medication in the visit to the physician
and also made a visit to the nursing homes to speak to
the staff. The intervention in Avorn 1992 [10] included
four educational meetings with nurses and assistant
nurses in addition to the outreach visit, and may there-
fore have been more intensive.
Drug use
A score for psychoactive drug use was developed in
Avorn 1992 [10] to assess the appropriateness of drug
use. At post-test the mean difference in favour of the
intervention group was -0.37 scores (95% CI -0.08 to
-0.67) and 18% fewer residents compared to the control
group used antipsychotic drugs (95% CI -3 to -33%).
Crotty et al. 2004a [13] measured the prescription rate
for psychotropics. The relative risk for having psycho-
tropics prescribed was not statistically significant (RR
0.89 95% CI 0.69 to 1.15), neither was the number of
regularly used psychotropics (RR 0.93 95% CI 0.82 to
1.05).
Health-related outcomes
No statistically significant difference in number of falls
between the two groups during the previous three
months was reported (Crotty 2004a [13]): RR 1.17 (95%
CI 0.86 to 1.58). None of the other health-related out-
comes were measured.
Summary and quality of evidence
Educational outreach combined with education of key
health personnel may in some circumstances lead to a
small reduction in inappropriate drug use. However, the
quality of evidence for this result varies from low to
very low (GRADE summary of findings in Additional
file 1, Table S4). Number of falls was the only health-
related outcome measured, but the quality of the evi-
dence was too low to draw any conclusions.
Educational meetings interventions
Five studies conducted in 32 nursing homes with a total
of 811 residents examined the effect of educational
meetings in the work setting (Fossey 2006 [16], Kuske
2009 [19], McCallion 1999 [21], Stein 2001 [27], Testad
2010 [30]) (details in Table 2). The educational interven-
tions were heterogeneous both in contents, e.g. commu-
nication skills training and training in person-centred
care, in intensity of the intervention and in measure-
ments. However, all educational activities seem to have
been of low intensity, with maximum duration of 13
hours (Kuske 2009 [19]) or two days (Testad 2010 [30]).
One study only stated having carried out a 10-month
training intervention without specifying the number of
hours (Fossey 2006 [16]).
Drug use
After ten months training and support for the health
personnel in person centred care and the use of alterna-
tives to drugs for agitated behaviour in dementia, the
weighted mean difference in favour of the intervention
group for reduced use of neuroleptics was 19.1% (95%
CI 0.5% to 37.7%) (Fossey 2006 [16]). There was no
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statistically significant difference between groups for use
of other psychotropic drugs (weighted mean difference
-5.9% (CI -27.2% to 5.5%)).
Residents’ use of sedative drugs after a 13-week small
groups training program targeted at all nursing home
staff members was examined in another study (Kuske
2009 [19]). The program was based on focus groups and
a literature study. The use of sedative drugs in the inter-
vention group was not statistically significantly different
from the use in the control group at six months.
Psychotropic drug use was measured in a study of a
communication skills program for nursing assistants
(McCallion 1999 [21]). At six months the residents in
the intervention group received psychotropic medication
for an average of 1.30 days (SD 2.15) compared to the
control group average of 1.57 (SD 1.71) days during the
previous week. The difference was not statistically
significant.
Use of non-steroidal anti-inflammatory drugs
(NSAIDs) and use of acetaminophen as the preferred
drug was measured at three months in an educational
program for physicians and other staff (Stein 2001 [27]).
The mean difference between groups for the use of
NSAIDs was -4.3 days less use (95% CI -6.41 to -2.19)
in the intervention group for the last seven days. The
mean difference between groups for the preferred drug
acetaminophen, in favour of the intervention group, was
3.0 days (95% CI 1.53 to 4.47) for the last seven days.
The proportion of residents using antipsychotic drugs
was measured in a study of the educational and training
program Relation-Related Care (Testad 2010 [30]). In
the intervention group 29% used antipsychotics immedi-
ately after the intervention and 32% six months later
versus 14% and 9% respectively in the control group.
These differences were not statistically significant (no
confidence intervals reported).
Table 1 Description of included primary studies for the comparison educational outreach versus usual practice
Study Participants Intervention Comparison Outcomes
Avorn
1992
[10]
Physicians, nurses and nursing assistants
in 6 nursing homes with 431 residents
in the experiment group and 6 nursing
homes with 392 residents in the control
group in the US.
Age: Not reported.
Aimed to reduce the excessive use of
sedating drugs. Three interactive
educational outreach visits by a
pharmacist to nursing home physicians
to reduce the use of psychoactive drugs.
Only physicians that exceeded a
treshold value for psychoactive drug
prescribing at the baseline evaluation
were targeted. Six literature summaries
done by research team on e.g.
management of insomnia, confusion
and agitation were disseminated to all
physicians in three mailings and used as
discussion aids in the educational visit.
Four training sessions were held for
nurses and nursing assistants in separate
groups on patient care, alternatives to
psychoactive drugs and adverse effects.
Extent of implementation: Not
reported.
Usual care. Score for use of psychoactive drugs,
proportion of residents using
antipsychotics.
Crotty
2004a
[13]
61 physicians, nurses and nursing
assistants in 10 nursing homes with 381
residents in the experiment group and
37 physicians with other health
personnel in 10 nursing homes with 334
residents in the control group.
Mean age: 84 years.
Aimed at implementing evidence based
practice in residential care. Doctors
received two 30 minute educational
outreach visits by a pharmacist in their
offices. The risks of psychotropic drug
use was one of several other key
messages, combined with detailed audit
information on fall rates, psychotropic
prescribing patterns and stroke risk
reduction practices in the nursing home
of each physician. A link nurse was
appointed at each facility. The link
nurses were trained in four two hour
sessions in which medication
management was one of the topics.
Also, a pharmacist visited each nursing
home and spoke to staff about reducing
the use of psychotropic medication.
Extent of implementation: Not
reported.
Usual care Percentage of residents prescribed and
administered any psychotropic
medication, percentage of residents
who had a fall incident in a 3 month
period.
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Table 2 Description of included primary studies for the comparison educational meetings and workshops versus usual care
Study Participants Interventions Comparison Outcomes
Fossey
2006 [16]
Health personnel in 6 nursing homes with
181 residents in the intervention group and
6 nursing homes with 168 residents in the
control group
Median age: 82 years (range 53-101).
Aimed at reducing the prescribing of neuroleptics for
residents with dementia. Ten month educational program
delivered by a psychologist, occupational therapist or
nurse with a focus on alternatives to drugs for managing
agitated behaviour in dementia. The staff received training
in providing person centered care and to develop skills
through didactic instruction, skills training and weekly
supervision and follow up both in groups and individually.
The programme entailed a ‘systemic consultation
approach’.
Extent of implementation: Not reported.
Usual care. Percentage of residents using
neuroleptics, percentage of
residents with at least one fall.
Kuske
2009 [19]
Two nursing homes with 89 caregivers and
68 residents allocated to the intervention
group and two nursing homes with 94
caregivers and 74 residents allocated to the
control group, in Germany.
Mean age: 81 years.
Aimed at increasing the caregivers’ knowlegde and
competencies for dealing adequately with residents with
dementia and reducing the number of residents who were
given sedative drugs and/or being physically restrained. A
training program that consisted of five modules (13 one
hour educational meetings in a 13 week intervention
period) was developed using focus groups and review of
international literature to find the key problem areas. The
aim was to improve the interaction between caregivers
and residents by improving caregivers knowledge and
expertise in providing care to residents with dementia.
Lectures were given by health care researchers with
practical experience in nursing in small groups of max 12
participants. Didactic teaching methods were used for the
theoretical introduction and problem based learning
methods for practical learning and skills training.
Extent of implementation: Caregivers that did not attend
at least 10 sessions (i.e. 40% of caregivers) were excluded.
Control 1: A group that was on the waiting
list. Control 2: A group of health
professionals who received relaxation. This
comparison has not been included here.
Percentage of residents using
sedative drugs, percentage of
residents exposed to physical
restraint.
McCallion
1999 [21]
39 nursing assistants in one unit in one
nursing home with 49 residents in the
intervention group and 49 nursing assistants
in one unit in one nursing home with 56
residents in the control group in USA.
Mean age: 84 years.
Aimed at improving the well being of nursing home
residents with dementia by means of a communication
skills program for nursing assistants. Education delivered
by a master’s level social worker with practical experience.
Alternately group instruction in small groups five times à
45 minutes and individual conferences à 30 minutes four
times (for skills training and feedback). The program
addressed four areas: knowledge of dementia, verbal and
nonverbal communication, memory aids and problem
behaviours.
Extent of implementation: Not reported.
Usual care for the control group in the 6
months that the intervention lasted for the
experimental group. Then, the control group
also received the same intervention for 3
months and both groups were measured
again at 9 months (we used data from the
6 month measurements).
Number of days the previous
week that residents used
psychotropic drugs, number of
days the previous week that
restraints were used.
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Table 2 Description of included primary studies for the comparison educational meetings and workshops versus usual care (Continued)
Stein
2001 [27]
Health personnel and 76 residents aged 65
years and more taking non steroidal anti-
inflammatory drugs (NSAIDs) regularly in 10
nursing homes in the intervention group
and 71 residents taking NSAIDs regularly in
10 nursing homes in the control group in
USA.
Age: ≥65 years.
Aimed at reducing the use of NSAIDs in the management
of osteoarthritis in nursing home residents. The
educational programme focused on alternative approaches
to NSAIDs to relieve muscle and joint pains in residents, e.
g. use of acetaminophen. One meeting with both the
administrative and professional management and a
separate meeting with each nursing home study
coordinator to review the purpose and educational
materials during the initial phase of the project, a 30
minute structured teaching session for physicians and
nursing staff.
Extent of implementation: On average, in each nursing
home it was estimated that 60-65% of all staff received the
educational programme.
Usual care Use of NSAIDs and
acetaminophen the past seven
days.
Testad
2010 [30]
197 care staff. Two nursing homes with 113
residents in the intervention group and two
nursing homes with 98 residents in control.
Median age 86 years.
Aimed at reducing agitation in residents with dementia,
use of restraints and antipsychotic drugs. Relation Related
Care education and training program, consisting of
predisposing, enabling and reinforcing elements.
Organized as a two day seminar and monthly group
guidance for six months.
Extent of implementation: “All care staff with and
without formal education, including leaders and domestic
staff, participated... [...] During the study period, there was
considerable turnover of staff...": 56 (54%) remained in
intervention and 53 (57%) in the control group.
Usual practice. Percentage of residents taking
antipsychotic drugs, use of
restraint.
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Health-related outcomes
The proportion of residents with at least one fall in the
past 12 months was measured in one of the studies
(Fossey 2006 [16]). There was no statistically significant
difference between the two groups (weighted average
difference 2.6% (95% CI -18.7 to 23.8)). Use of physical
restraint (bed fences, chair that prevents ascension, etc.)
was measured in three of the studies. In the study by
Kuske 2009 [19] results were reported as coefficients
with standard deviations. The use of restraints increased
significantly more in the control group compared to the
intervention group (p = 0.045 when comparing change
in the groups as the number of residents who had been
subject to physical control during the study sequence).
In the study by McCallion 1999 [21] no statistically sig-
nificant differences between the groups were recorded:
1.88 (SD 1.82) days of physical restraint in the preceding
week in the intervention group compared to 1.75 (SD
1.42) in the control group. The third study reported no
statistically significant difference between groups for
‘interactional’ physical restraint (force or pressure in
medical examination, treatment or in activities of daily
living) (Testad 2010 [30]). Immediately after the inter-
vention period 48% of residents in the intervention
group had been subjected to physical restraint versus
46% in the control group.
Summary and quality of evidence
Educational meetings may in some circumstances lead
to a small reduction in use of drugs in nursing homes.
However, the evidence for this result varies from low to
very low quality (GRADE summary of findings in Addi-
tional file 1, Table S5). The quality of the evidence for
the effect of these interventions on health-related out-
comes is too low to draw any conclusions.
Educational meetings with at least one additional
intervention
We included three studies conducted in 88 nursing
homes with 8599 residents that used at least one more
intervention in addition to educational meetings (Loeb
2005 [20], Meador 1997 [22], Roberts 2001 [24]) (details
in Table 3). The main additional intervention in all stu-
dies was educational outreach. One of the studies also
had a partial medical review with recommendations to
physicians (Roberts 2001 [24]).
Drug use
The number of prescriptions for antibiotics for sus-
pected urinary tract infection per 1000 resident days
was reported in a study of interactive teaching of nurses,
combined with procedural tools and educational out-
reach (Loeb 2005 [20]). Although the weighted mean
difference was statistically significant at 12 months
(-0.49 prescriptions per 1000 resident days (95% CI
-0.93 to -0.06)), the difference in total number of pre-
scriptions for antibiotics was not (-0.37 prescriptions per
1000 resident days (95% CI -1.17 to 0.44)).
Use of antipsychotics at 6 months was measured in a
study of an educational program combined with educa-
tional outreach visits (Meador 1997 [22]). The mean dif-
ference in consumption of antipsychotics was
statistically significant in favour of the intervention
group for the last preceding 30-day period (-6.30 days
per 100 resident days (95% CI -6.55 to -6.05)).
The proportion of residents that used psychotropic
drugs was measured in a study that examined the effect
of a year long clinical pharmacy program involving
development of professional relationships, nurse educa-
tion on medication issues, and individualised medication
reviews (Roberts 2001 [24]). The result was not statisti-
cally significant (RR 0.91 (95% CI 0.83 to 1.00) at 12
months.
Health-related outcomes
Two studies measured mortality and number of admis-
sions to hospital (Loeb 2005 [20], Roberts 2001 [24]),
but no statistical significant differences between groups
were found.
Summary and quality of evidence
Educational meetings with at least one additional inter-
vention may in some circumstances lead to a small
reduction in use of drugs in nursing homes. However,
the evidence for this result is of low quality (GRADE
summary of findings in Additional file 1, Table S6). No
statistically significant effects were demonstrated for
number of hospitalisations or mortality and the quality
of the evidence for these results is too low to draw any
conclusions.
Medication review
We included seven studies conducted in 255 nursing
homes with 3212 residents that examined the effect of
medication review with a pharmacist (Furniss 2000 [17],
Zermansky 2006 [28], Schmidt 1998 [26], Crotty 2004b
[14], Crotty 2004c [15], Patterson 2010 [29], Midlöv
2002 [23]) (details in Table 4). Reviews were made
either by the pharmacist alone (Furniss 2000 [17]; Zer-
mansky 2006 [28]), as part of a team (Schmidt 1998
[26]; Crotty 2004b [14]; Crotty 2004c [15]), with the
pharmacist discussing the results of the medical review
with nursing staff and physicians separately (Patterson
2010 [29]) or together with other specialists, resulting in
a letter to the residents’ physician (Midlöv 2002 [23]). In
the latter study, it was unclear whether these specialists
were external experts or were working at the nursing
home.
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Drug use
Number of drugs prescribed was used to measure the effect
of a medication review in one study (Furniss 2000 [17]).
The mean difference between groups at eight months,
adjusted for baseline differences, was not statistically signifi-
cant (0.5 prescriptions (95% CI -0.04 to 1.0; p = 0.07).
In Zermansky 2006 [28] the effect of the medication
review was measured as mean number of drug changes.
Although a statistically significant difference in favour of
the intervention group was found at six months (ratio of
means 1.34 (95% CI 1.21 to 1.48)), there were no statis-
tically significant differences between groups for the
total number of drugs used (ratio of means 0.98 (95%
CI 0.92 to 1.04).
The total number of prescriptions for any psychotro-
pic drug was measured in a study investigating the effect
of regular multidisciplinary team meetings (Schmidt
1998 [26]). Each resident’s medication was discussed in
pursuance of the guidelines from the Swedish Medical
Product Agency. A pharmacist organised and partici-
pated in the meetings. The difference in total number of
prescriptions for any psychotropic drug was not statisti-
cally significantly different between the groups at one
month follow-up (RR 0.97 (95% CI 0.92 to 1.03)). The
authors also analysed use of the various kinds of psycho-
tropic drugs: antipsychotics, hypnotics, anxiolytics and
antidepressants. However, change was reported for each
group separately and not compared between the groups,
Table 3 Description of included primary studies for the comparison educational meetings and workshops with other
co-interventions versus usual care
Study Participants Interventions Comparison Outcomes
Loeb
2005
[20]
Nurses and physicians, 2156
residents in 12 nursing
homes participated in the
intervention group and 2061
residents in 12 nursing
homes partcipated in the
control group in USA and
Canada.
Age not reported.
Aimed at reducing the number of prescriptions for
antimicrobials for suspected urinary tract infections.
Multifaceted intervention: Diagnostic and treatment
algorithm for urinary tract infections introduced to
physicians and nurses, small group interactive sessions
with case scenarios for nurses, videotapes, outreach visits
to the physicians that cared for 80% or more of the
residents, visits from the researchers every three months to
address any questions, one nurse in each nursing home
appointed to remind nurses to use the algorithm.
Extent of implementation: Not reported.
Usual care. Number of amtimicrobial
prescriptions for suspected
urinary tract infection per
1000 resident days, total
number of prescriptions for
amtimicrobials per 1000
resident days, number of
admissions to hospital,
mortality.
Meador
1997
[22]
Health personnel and 575
residents in 6 nursing homes
in the intervention group and
577 residents in 6 nursing
homes in the control group
in USA.
Age: ≥65 years
Aimed at reducing antipsychotic use in nursing homes
with high use rates. Physicians, nurses, nursing assistants
and other direct care staff were trained to use structured
guidelines. Educational outreach: A geropsychiatrist visited
all physicians who had five or more patients in the home
to dicuss risks and benefits of antpsychotics and delivered
printed material. Educational meetings: A trained nurse
educator conducted five to six 1 hour inservice programs
(including case examples, role playing and problem
solving sessions) for staff over a 1 week period. Four weeks
after the inservice programs were completed, a follow up
session was conducted for the staff. Further consultations
and meetings could be arranged if requested (it is not
reported if it was).
Extent of implementation: Not reported.
Usual care
and waiting
list.
Use of antipsychotics as
registered in the medication
administration records.
Roberts
2001
[24]
Nurses, 905 residents in 13
nursing homes in the
intervention group and 2325
residents in 39 nursing
homes in Australia.
70% of residents ≥80 years
Aimed at changing drug use, mortality and morbidity. 12
months intervention involving three phases: introducing a
new professional role to stakeholders with relationship
building, nurse education and medication review by
pharmacists. In focus groups, written and telephone
communication and face to face professional contact
between nursing home staff and clinical pharmacist drug
policies and resident problems were dicussed. 6-9 problem
based education sessions (11 hours total) were held for
nurses. The subjects were geriatric pharmacology,
depression and dementia, incontinence, falls, insomnia,
constipation, and pain supported by wall charts, bulletins,
telephone calls and visits by clinical pharmacists (average
contacts per nursing home was 26 h). For 500 selected
residents clinical pharmacists wrote down the results of
their review of medication, which was then discussed with
the nurses and included in each patient’s record and thus
made available to the residents’ physician.
Extent of implementation: Not reported.
Usual care. Percentage of residents being
administered psychotropic
medication, mortality, number
of hospitalisations.
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Table 4 Description of included primary studies for the comparison medical review by pharmacist versus usual care
Study Participants Intervention Comparison Outcomes
Crotty
2004b [14]
Physicians, registered nurses, 56 residents in
the intervention group and 54 residents in
the control group that were assigned to 85
long term care facilities in Australia.
Mean age: 83 years.
Aimed at improving medication management services by
transferring information on medications to care providers
in the longterm care facilities. The transition pharmacist
compiled a medication transfer summary and faxed this to
the family physician and the community pharmacist. The
pharmacist coordinated an evidence based medication
review that was to be performed by the community
pharmacist contracted to the facility within 14 days of the
transfer. After this, the transition pharmacist also arranged
and participated in a case conference with the family
physician, the community pharmacist and a registered
nurse at the facility within a month of the transfer.
Extent of implementation: Medical review was
performed for 36 residents (64%). Case conferences took
place for 8 residents (14%).
Usual care: Standard
hospital discharge
summary.
Medication Appropriateness Index score, falls,
hospital admissions (emergency visits and
readmissions).
Crotty
2004c [15]
General practitioners, geriatricians,
pharmacists, residential care staff, 50 residents
in 5 nursing homes in the intervention group
and 50 residents in 5 nursing homes in
control group 1 and 54 residents in control
group 2 (not included here) in Australia.
Mean age: 85 years.
Aimed at improving appropriateness of medications. Two
multidisciplinary case conferences (GP, geriatrician,
pharmacist, residential care staff, representative of the
Alzheimer’s Association of South Australia) were conducted
6-12 weeks apart. A medical review was prepared
beforehand by the resident’s GP.
Extent of implementation: Not reported.
Usual care. Both groups
received a half day
education in how to handle
behaviour problems in
residents with dementia.
MAI (Medication Appropriateness Index)
score, number of drugs.
Furniss
2000 [17]
158 residents in 7 nursing homes in the
intervention group and 172 residents in 7
nursing homes in the control group in
United Kingdom.
Mean age: 81 years.
Aimed at reducing the number of prescribed drugs. The
pharmacist collected details of current medication for each
resident from the Medicines Administration Record chart
in each home, compiled a brief medical history and made
the staff identify any current problems. The pharmacist
checked whether the use of neuroleptics were in
accordance with the US Ombudsman Reconciliation Act
guidelines and made suggestions for change of
medication if necessary. Three weeks afterwards, the
homes were revisited to identify any immediate problems
and to check on whether changes had been
implemented.
Extent of implementation: Not reported.
Usual care. Mean number of prescribed drugs.
Midlöv
2002 [23]
41 residents with epilepsy in the intervention
group and 33 residents in the control group;
51 residents with Parkinson in the
intervention group and 33 residents in the
control group in 48 nursing homes in
Sweden.
Mean age: 80 years.
Aimed at improving the pharmacological treatment.
Pharmacists reviewed and documented the patients’ drug
use and any problems related to the drug use as reported
by the residents, their contact person at the nursing home
and the resident’s physician. A multidisciplinary team
consisting of the data collecting pharmacist, a pharmacist
with a special experience in neurology, a primary care
physician, neurologist, neuropsychiatrist and a clinical
pharmacologist discussed the collected information and
made suggestions. A list of recommended changes in
medication was sent to the resident’s physician.
Extent of implementation: Not reported.
Usual care. Number of drugs.
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Table 4 Description of included primary studies for the comparison medical review by pharmacist versus usual care (Continued)
Patterson
2010 [29]
11 nursing homes with 173 residents in
intervention group and 11 nursing homes
with 161 residents in control group.
Mean age: 83 years.
Aimed at reducing inappropriate prescription of
psychoactive medications and falls. Specially trained study
pharmacists visited nursing homes monthly for 12 months.
Information for each resident was collected from the
nursing home record, the GP and from the local
community pharmacist if needed. The residents
themselves, their nurses and next of kin were interviewed
to assess residents’ need for medication. An algorithm
were used by pharmacists for guidance in assessing the
inappropriateness of psychoactive medication.
Recommendations were discussed with nursing staff.
Meetings were held with the residents’ GP to discuss and
decide about medication and feedback were given to
nursing staff.
Extent of implementation: Not reported.
Usual care. Proportion of residents prescribed one or
more inappropriate psychoactive (anxiolytic,
hypnotic or antipsychotic) drugs, change in
number of inappropriate psychoactive drugs,
rate of falls per 100 resident months.
Schmidt
1998 [26]/
Claesson
1998 [12]
626 residents in 15 nursing homes in the
intervention group and 1128 residents in 18
nursing homes in the control group in
Sweden.
Mean age: 83 years.
Aimed at minimising the use of nonrecommended drugs
as defined by guidelines from the Swedish Medical
Product Agency. One pharmacist was appointed from the
local pharmacy to spend one day per month in a nursing
home. The pharmacist attended two training sessions in
geriatrics, drug use and in interdisciplinary collaboration
methods before the intervention and three sessions during
the 12 months intervention. The appointed pharmacists
helped in organising monthly multidisciplinary meetings to
discuss and improve the use of drugs that could cause
confusion and memory impairment. A physician,
pharmacist and selected nurses and nursing assistants
participated in discussing each resident’s drug use. The
length of the meetings was locally adapted. Pharmacists
formed regional networks to support their function in the
project.
Extent of implementation: Not reported.
Usual care. Number of prescriptions for any
psychotropic, antipsychotics, hypnotics,
anxiolytics, antidepressants.
Zermansky
2006 [28]
661 residents on one or more drugs selected
from 65 nursing homes in United Kingdom:
331 allocated to the intervention group and
330 to the control group.
Mean age: 85 years.
Medical review by a pharmacist by using the patient’s
clinical record and by consultation with the patient and
carer. On this basis, the pharmacist made
recommendations and forwarded them on a written
proforma to the GP for acceptance and implementation.
The GPs indicated acceptance by ticking a box on the
proforma.
Extent of implementation: Not reported.
Usual care. Number of changes in medication per
resident, total number of drugs used.
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which make it difficult to know the effect estimate for
use of each drug group. Because of baseline differences,
dependency between baseline and post intervention
values and the cluster design, it was not appropriate to
reanalyse on the basis of the summary statistics pre-
sented in the paper.
Two studies by Crotty and colleagues measured Medi-
cation Appropriateness Index (MAI) scores after medi-
cation review by a pharmacist working in a team. In
Crotty 2004b [14], the mean difference in MAI score at
eight months follow-up was -4 (95% CI -6.76 to -1.24)
in favour of the intervention group. However, the differ-
ence was due to a worsening in the MAI score in the
control group whereas the score in the intervention
group did not change. In Crotty 2004c [15], The MAI
score improved significantly in the intervention group
compared to the control group (4.1 (95% CI 2.1 to 6.1)
versus 0.4 (95% CI -0.4 to 1.2); p < 0.001) at three
months after start of the intervention. However, there
was no statistical significant difference between groups
in number of drugs used.
In Patterson 2010 [29], an algorithm was used to
decide the inappropriateness of psychoactive medication.
The difference in proportion of residents taking psy-
choactive drugs at 12 months was statistically signifi-
cant, 20% in the intervention group versus 50% of
residents in the control group (OR 0.26 (95% CI 0.14 to
0.49)).
Use of drugs by residents with Parkinson’s disease or
residents with epilepsy was measured in a study that
examined the effect of a combined pharmacist/specialist
medication review (Midlöv 2002 [23]). No statistically
significant differences in change scores were found
between intervention and control groups. The change
score in the intervention group was 0.19 drugs versus
0.56 for the control group (p = 0.26) in residents with
epilepsy and -0.14 drugs versus 0.07 drugs (p = 0.88) in
residents with Parkinson’s disease.
Health-related outcomes
Number of falls during the intervention period was
measured in three of the studies (Crotty 2004b [14],
Furniss 2000 [17], Patterson 2010 [29]) and number
of patients that fell was measured in a fourth study
(Zermansky 2006 [28]). None of them found any statis-
tically significant effects. There was, however, a statisti-
cally significant reduction of falls per resident in the
intervention group in one study measuring this (ratio
of means of 0.59 (95% CI 0.49 to 0.70)) (Zermansky
2006 [28]).
Number of hospital admissions was measured in two
of the studies (Zermansky 2006 [28], Crotty 2004b [14]).
When data for deceased residents were included, there
were no statistically significant differences between
groups at eight weeks in the study by Crotty 2004b [14]
(RR 0.58 (95% KI 0.28 to 1.21)). Neither was any statisti-
cally significant results for being admitted to hospital
during a 6-month period reported in Zermansky 2006
[28] (OR 0.89 (95% CI 0.56 to 1.41)).
Two of the studies also measured mortality (Furniss
2000 [17], Zermansky 2006 [28]). In Furniss 2000 [17],
mortality was lower in the intervention group for the
intervention period, but not for the study period: 4
deaths in the intervention group versus 14 deaths in the
control group (p = 0.028). No statistically significant dif-
ference in mortality during the last six months was
reported in Zermansky 2006 [28] (OR 0.89 (95% KI 0.56
to 1.41)).
Summary and quality of evidence
Medication review by a pharmacist in teamwork with
other health personnel may in some circumstances lead
to a small change in use of drugs in nursing homes.
However, the quality of the evidence for this result var-
ied from low to very low (GRADE summary of findings
in Additional file 1, Table S7). Only one of the studies
indicated both a statistically significant change in use of
drugs and a positive change in number of falls per resi-
dent. However, the quality of the evidence for all of the
measured health-related outcomes; use of hospital ser-
vices, falls or mortality, is too low to draw any
conclusions.
Medical care by a geriatric assessment team
Medical care by a geriatric assessment team compared
to standard care with regard to use of drugs was tested
in only one study including a single nursing home with
69 residents (Cavalieri 1993 [11]) (details in Table 5).
Drug use
Statistically significantly fewer drugs were prescribed for
the intervention group at three months than for the
control group (mean difference -2.3 drugs 95% CI -4.58
to -0.02).
Health-related outcomes
There were no statistically significant differences
between intervention and control groups in number of
hospitalisations (mean 0.6 admissions in both groups) or
number of days alive (274 days since study recruitment
in the intervention group versus 235 days in the control
group).
Summary and quality of evidence
Medical care by a geriatric assessment team led to sta-
tistically and clinically significant fewer drugs being
prescribed when compared to usual care. No statisti-
cally significant effect was demonstrated for the single
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health-related outcome measured, which was number
of hospitalisations. However, the quality of the evi-
dence was graded as very low and no conclusions
about the effect of geriatric assessment teams may be
drawn (GRADE summary of findings in Additional file
1, Table S8).
Early psychiatric intervention by a psychogeriatric team
We identified only one study, conducted in 22 nursing
homes with 106 residents, that examined the effect of
early psychiatric intervention for use of psychotropic
drugs and physical restraint (Kotynia-English 2005 [18])
(details in Table 6).
Drug use
There were no statistically significant differences
between intervention and control groups in the use of
psychotropics at 12 months (regular use RR 1.08 (95%
CI 0.80 to 1.46) or in occasional use of psychotropics
(RR 0.89 (95% CI 0.77 to 1.03)).
Health-related outcomes
No statistically significant effect was found for use of
physical restraint (RR 1.44 (95% CI 0.55 to 3.76)).
Summary and quality of evidence
Early psychiatric intervention by a psycho-geriatric team
did not demonstrate any statistically significant effect on
use of drugs or physical restraint. The quality of the evi-
dence was graded as very low and no conclusions about
the effect may be drawn (GRADE summary of findings
in Additional file 1, Table S9).
Activity program for residents
One study conducted in a single nursing home with 81
residents examined the effect of a program for dementia
care (Rovner 1996 [25]) (details in Table 7). The inter-
vention consisted of an activity program for residents,
guidelines for prescription of psychotropic drugs with
transfer of prescribing responsibility from the general
practitioner to the psychiatrist as well as one-hour meet-
ings each week for six months between the psychiatrist
and the activities staff to discuss each patient’s beha-
vioural, functional and medical status.
Drug use
At six months follow-up there were no statistically sig-
nificant differences between the intervention and control
groups for the use of antipsychotic drugs (RR 0.52 (95%
Table 5 Description of included primary studies for the comparison geriatric assessment team versus usual care
Study Participants Intervention Comparison Outcomes
Cavalieri
1993
[11]
33 residents assigned to the
intervention group and 36
residents to the control group in
the same nursing home.
Mean age: 82 years.
Aimed at identifying potential healthcare
outcomes, e.g. reduction of prescription of
drugs. A Comprehensive Geriatric Assessment
Team: Team of geriatricians and geriatric
nurse practitioners. The team evaluated each
residents on arrival to the nursing home and
was responsible for all medical treatment
during the study period.
Extent of implementation: Not reported.
Usual care: residents
managed by individual
physicians without formal
training in geriatrics.
Number of drugs
prescribed, hospital
admissions/use of
health care services.
Table 6 Description of included primary studies for the comparison early psychiatric intervention versus usual care
Study Participants Intervention Comparison Outcomes
Kotynia
English
2005
[18]
53 residents in the
intervention group and 53
residents in the control group
in 22 nursing homes in
Australia.
Mean age: 84 years.
Aimed at improving mental health and
physical outcomes by early detection of
symptoms, thereby indirectly reducing
the need for psychotropic medication.
Psychiatric assessment of all residents in
the intervention group. Residents
attaining a GDS-15 (Geriatric Depression
Scale) score greater than 5 or a NPI
(Neuropsychiatric Inventory) score
greater than zero in any of its 12
sections were referred to a
psychogeriatric multi disciplinary team
for treatment and systematic follow up
untill the problem was solved (usually ca
3 months).
Extent of implementation: All the
residents were screened but no other
information than that residents were
referred when needed.
Usual care, i.e. when residents screened
positively, they were not automatically
referred to psychiatric treatment but
only if it was judged necessary.
Use of psychotropic
agents or use of
PRN medication,
physical restraint.
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CI 0.26 to 1.04)) or number of drugs per resident (mean
difference 0.60 (95% CI -0.90 to 2.10)).
Health-related outcomes
Physical restraints were significantly less used in the
intervention group during activity, which were arranged
outside the nursing unit, compared with controls (RR
0.49 (95% CI 0.25 to 0.95)). However, there was no sta-
tistically significant difference between the groups in
physical restraint use when both groups stayed in the
nursing unit (RR 0.65 (95% CI 0.39 to 1.09)).
Summary and quality of evidence
An activity program for residents did not demonstrate
any statistically significant effect on use of drugs, but
did indicate a statistically significant effect in use of phy-
sical restraints during activity. However, the quality of
the evidence was graded as very low and no conclusions
about the effect of activity programs may be drawn
(GRADE summary of findings in Additional file 1, Table
S10).
Discussion
In this review we identified, assessed and summarised
evidence of the effect of interventions with a primary or
secondary aim of reducing potentially inappropriate use
of drugs in nursing homes. We identified 20 randomized
controlled trials conducted in 431 nursing homes invol-
ving 14 416 residents and an unknown number of
health personnel, but no systematic reviews that met
our inclusion criteria. Three of our comparison
categories (including a total of ten studies) compared an
educational initiative of some kind with practice as
usual, while one comparison category (including seven
studies) tested medical review against usual practice. For
the other three comparison categories geriatric teams,
early psychiatric intervention and activity program for
residents, we identifed only one study for inclusion in
each category.
Five of the ten studies that tested the effect of educa-
tional initiatives reported a statistically significant effect
for at least one outcome measure on the use of drugs.
However, it was not possible to determine whether any
of the three types of educational interventions (educa-
tional outreach initiatives, educational meetings alone or
as a part of a complex intervention) had a better effect
than the others. However, these studies represent only a
small subset of the many studies of the effect of educa-
tional interventions in other environments involving
health personnel. Systematic reviews with a broader
scope than ours have concluded that there is a small,
general effect on health professionals’ practice and an
even smaller effect on patient outcomes of all the three
types of educational interventions examined in our
review [32,33]. The quality of the evidence for these
results was graded as moderate [33]. The effects, how-
ever, varied from study to study without obvious rea-
sons. This may at least partly be explained by a complex
interaction of the degree of implementation of the edu-
cation programme, the intensity of the programme
(which is usually very low in these kind of studies),
teaching methods and their quality, characteristics of
Table 7 Description of included primary studies for the comparison activity program versus usual care
Study Participants Interventions Comparison Outcomes
Rovner
1996
[25]
42 residents in the
intervention group and
39 residents in the
control group in a 250
beds nursing home in
USA.
Mean age: 82 years.
Aimed at reducing behaviour disorders in residents with
dementia. Program with three components:
- Daily 5 hours activity program with music, exercise, crafts,
relaxation, reminiscences, word games and food
preparation
- Guidelines for psychotropic drug management.
Psychotropic drugs were considered as potentially
inappropriate and the aim was to reduce their use.
Prescribing were turned over to the psychiatrist.
- Weekly 1 hour educational meetings between the study
psychiatrist and activities staff that focused on patients’
predisposing features to behavioural disorders. Each
patient’s behavioral, funtional and medical status were
discussed.
Extent of implementation: Thirty-eight of 42 (92.8%)
intervention patients attended the activity program daily.
Three patients and one patient’s family refused
participation. On average, intervention patients spent 17.0
(5.9) hours per week in the activity program. Activity levels
for controls were observed four times during the 6 month
period (months 2, 3, 5, 6) and revealed that an average of
23.4% (5.1) participated in nursing home provided
activities. At 6 months, intervention patients were more
than 10 times more likely to participate in activities than
were controls (OR = 13.71; 95% CI [4.50, 41.73]; P <.001).
Usual care, i.e. each resident
had about 3 to 6 activity hours
each week: discussion group,
arts and crafts, special programs
with outside entertainers and
bedside sensory stimulation.
The physician could make
contact with the psychiatrist if
needed. Usual care was
modified by the intervention:
when intervention residents
participated in acitivites
elsewhere, the nurse to resident
ratio increased in the nursing
unit.
Number of
residents using
antipsychotics,
number of drugs,
use of physical
restraint.
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the organisation, how senior leaders and practitioners
perceive the seriousness of the outcomes and the com-
plexity of the desired change [33]. Educational interven-
tions alone can probably not be expected to change
behaviour when leaders and practitioners do not per-
ceive it to be important, or when the change is complex
and dependent on the interaction of many people
[32,33]. There is reason to believe that these considera-
tions also apply to educational programmes in nursing
homes. In conclusion, the results indicate that educa-
tional programmes for health personnel may have a
small effect on drug managing practice when circum-
stances are favourable. Although the quality of the evi-
dence for these results in nursing homes varies from
low to very low, the results are consistent with results
from systematic reviews of a much more comprehensive
evidence base [32,33].
Seven studies examined the effect of medication
review on drug use. The role of pharmacists varied from
doing a limited medication review with a passive
response to the doctor, to teaching and coordination
and involvement of other health care professionals in a
multidisciplinary team. In four of the studies there was
a statistically significant effect on at least one measure
of drug use (Crotty 2004b [13], Crotty 2004c [14], Zer-
mansky 2006 [28], Patterson 2010 [29]), whereas the
results in the remaining three were non-significant. In
two of these latter studies, the pharmacist did review
the drugs, but the end product seemed to be a written
recommendation to the doctor as the only follow-up.
This was also the case for the pharmacist medication
review performed in one of the studies that we classified
as educational meetings with at least one additional
intervention (Roberts 2001 [24]). In the third study
without a statistically significant effect the pharmacist
was active in a multidisciplinary team and presumably
gave recommendations or feedback orally during the
meetings, but without any medication review done
beforehand (Schmidt 1998 [26]/Claesson 1998 [12]).
All interventions that were examined in this review
are interventions known to be context dependent [9],
meaning that they may work in some contexts and not
in others. Contextual factors such as the success of
implementation of the intervention programme, charac-
teristics of the host organisation, local culture, degree of
support by organisational leaders, expertise of the inves-
tigational staff as well as the staff targeted by the inter-
vention, intensity and duration of the intervention and a
wide range of other factors will influence the effective-
ness of the intervention. It is, therefore, a general pro-
blem that interventions and settings are poorly
described with regard to detail as well as to the extent
of implementation. For example, only five out of twenty
included studies gave some information related to the
extent of implementation of the intervention (Crotty
2004b [14], Rovner 1996 [25], Stein 2001 [27], Kuske
2009 [19], Testad 2010 [30]). Consequently, reasons for
variations in effects are difficult to explain. However,
there are some findings from other reviews that could
tentatively illuminate some of the sources of heterogene-
ity. For example, passive feedbacks in the form of writ-
ten recommendations to the doctor can be interpreted
both as a reduction of the medication review to an
intervention consisting of printed material and as a
rather feeble feedback. The effect of printed material as
an intervention to change behaviour has been described
as uncertain [34]. Similarly, a previous systematic review
of audit and feedback interventions concluded that the
effect was probably greater the more intensive the feed-
back [35]. Therefore, in either case, in these three stu-
dies the feedback and follow-up may have been too
weak.
In conclusion, the results indicate that medication
review with the participation of a clinical pharmacist
may have a positive influence on the use of drugs in
nursing homes. This conclusion is consistent with the
more comprehensive evidence base in a systematic
review of interventions to improve the medication of
elderly in general [36]. However, even the quality of this
larger evidence base for these results was graded as low.
For our other three comparison categories, geriatric
assessment team (Cavalieri 1993 [11]), early psychiatric
intervention (Kotynia-English 2005 [18]) and activity
measures for the residents (Rovner 1996 [25]), there
were only one study with few participants and of high
or uncertain risk of bias in each comparison. The qual-
ity of the existing evidence is therefore too low to deter-
mine whether these interventions can influence drug
use or not, and suggests a need for larger studies of bet-
ter quality.
Some of the studies in this review only assessed the
level of drug use without considering the appropriate-
ness of the drugs prescribed and used. However, severe
adverse effects have been shown to be associated with
use of drugs like antipsychotics [37-39] and benzodiaze-
pines [36]. Monitoring and reducing or changing the
use of such drugs could therefore be an important goal
in itself.
Our preselected primary outcomes were prescription
and use of drugs. However, these outcomes are actually
related to process, whereas the ultimate goals are
improvement in quality of life for the residents and
reduction of adverse events. Because of the demon-
strated associations between intake of certain drugs and
health outcomes it is generally assumed that by reducing
these drugs health outcomes will be improved and
adverse effects reduced. Accordingly, health outcomes
would not be expected to improve if there is no effect
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on drug use. To the contrary, however, three studies
indicated small but apparently real changes in health-
related outcomes without any statistically significant
change in medication (Furniss 2000 [17], Kuske 2009
[19], Rovner 1996 [25]). Perhaps other factors in the
active intervention such as greater awareness among
staff regarding their own behaviour could explain this.
Of the nine studies that did detect a statistically signifi-
cant effect on drug use, five measured at least one of
our preselected health-related outcomes. Only one of
these had a statistically significant effect on one of the
health-related outcomes, i.e. number of falls per resi-
dent, although not for the total number of patients who
fell (Zermansky 2006 [28]).
It is important to be aware of the fact that the
boundaries between the categories we classified the
studies by are not clear cut. For example, both Roberts
2001 [24] and Crotty 2004a [13] could have been clas-
sified as medication reviews rather than as composite
educational intervention and educational outreach
initiatives, respectively. Also, several of the interven-
tions could have been classified as multifaceted but we
wanted to emphasise what we thought was the main
content. Likewise, interventions such as pharmacists
working in a multidisciplinary team could have been
classified as multidisciplinary.
Possible weaknesses
Although our literature search conforms with the cri-
teria for a systematic review and included screening for
references in included studies, weaknesses intrinsic to
any search strategy means that relevant studies may
have been missed. We did not look for grey literature
nor did we do any formal assessment of risk of publica-
tion bias. Also, in the screening process we may have
overlooked studies if drug use was not reported in the
abstract as one of the outcomes. In particular, this may
apply to studies of different activity and environmental
initiatives.
Conclusions
Our review indicates that interventions using educa-
tional outreach, on-site education given alone or as part
of an intervention package and pharmacist medication
review under certain circumstances may reduce inap-
propriate drug use in nursing homes. The evidence for
these results ranges from very low to low quality but is
supported by findings from other reviews of studies
from a wide range of health care settings. The quality of
the evidence for the results from the three other inter-
ventions that were examined, medical care by a geriatric
assessment team, early psychiatric intervention and
activity programme for residents was graded as very low
and no conclusions about their effect on drug use can
be drawn. For the same reason, no conclusions may be
drawn for the effect on health-related outcomes.
Implications for research and practice
Further research should concentrate on improving our
understanding of when interventions such as education
or medication reviews are likely to be effective and how
to improve them. Also, studies that examine the effect
of combined approaches, conducted by a multidisciplin-
ary team and structurally and organisationally integrated
in the institution are likely to be of interest. Many of
the studies described in this review were small or pro-
vided too little detail on design or how the interventions
were carried out, with very low quality of evidence as a
result. Therefore, it is important that further studies are
sufficiently powered and take greater care in describing
study and intervention conditions. Only then may con-
clusions be drawn on a reliable basis.
It has been pointed out that doctors, nurses and phar-
macists receive little training in drug treatment of older
people in their education [40]. Consequently, it is diffi-
cult to imagine any intervention for reducing drug use
that does not imply some kind of educational initiative.
Most likely, however, several measures of organisational
and structural character would have to be planned as
part of the managerial approach. This could comprise
organisation of continuous education of relevant health
personnel, allocation of time to make it possible for per-
sonnel to participate and explicit procedures and rou-
tines for medication review actively involving key
personnel in a multidisciplinary team setting. Carrying
out these activities should be endorsed and followed up
by those professionally responsible in the nursing home.
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